Russian officials said last fall that overseas manufacturing could partly meet demand at home, but have since gone quiet about importing a product that has been held up as a triumph of the country’s scientists. Manufacturing the vaccine in Russia, however, has been a different story.Russia trumpets vaccine exports, while quietly importing doses
Russian officials said last fall that overseas manufacturing could partly meet demand at home, but have since gone quiet about importing a product that has been held up as a triumph of the country’s scientists. Manufacturing the vaccine in Russia, however, has been a different story.
Subscribe to:
Post Comments (Atom)
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
-
In July, HCL Technologies had announced a Rs 4,000 crore buyback programme for FY19 at a price of Rs 1,100 per equity share.
No comments:
Post a Comment